# Interleukin-2 Therapy for HIV Infection - Supplemental Procedures

> **NCT00001354** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 60 (—)

## Conditions studied

- Acquired Immunodeficiency Syndrome
- HIV Infection

## Interventions

- **DRUG:** Interleukin-2/Zidovudine (AZT)

## Key facts

- **NCT ID:** NCT00001354
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-03
- **Primary completion:** —
- **Final completion:** 2002-03
- **Target enrollment:** 60 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001354, "Interleukin-2 Therapy for HIV Infection - Supplemental Procedures". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00001354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*